Recombinant RNasin(R) RNase Inhibitor, 2,500u
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0471990
- Awardee
- PROMEGA CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $138.60
About this award
The University of Virginia awarded a contract to Promega Corporation on August 21, 2026, for the delivery of laboratory reagents. The prime contractor will supply Recombinant RNasin (Ribonuclease Inhibitor) in a quantity of 2,500 units, with delivery to Charles Mitchell Boudreaux. The contract value totals $138.60, with a unit price of $138.60 per item ordered.
This procurement represents a single-line item purchase of a molecular biology product utilized in research and diagnostic applications. The contract was executed in Virginia through the University of Virginia's contracting organization. No specific performance period, renewal terms, or additional contract conditions are identified in the available contract documentation.
Line items
| Item | Total |
|---|---|
| Recombinant RNasin(R) RNase Inhibitor, 2,500u | $138.60 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0471990?
Contract A207_PO-0471990 was awarded to PROMEGA CORPORATION by University of Virginia on August 21, 2026.
How much is contract A207_PO-0471990 worth?
Its cumulative value is $138.60.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award